These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 37393902)

  • 1. The Narrative of a Patient with Leptin Receptor Deficiency: Personalized Medicine for a Rare Genetic Obesity Disorder.
    Welling MS; Kleinendorst L; van Haelst MM; van den Akker ELT
    Obes Facts; 2023; 16(5):514-518. PubMed ID: 37393902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of novel LEPR mutations in Pakistani families with morbid childhood obesity.
    Niazi RK; Gjesing AP; Hollensted M; Have CT; Grarup N; Pedersen O; Ullah A; Shahid G; Ahmad W; Gul A; Hansen T
    BMC Med Genet; 2018 Nov; 19(1):199. PubMed ID: 30442103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of setmelanotide, an MC4R agonist, in individuals with severe obesity due to LEPR or POMC deficiency: single-arm, open-label, multicentre, phase 3 trials.
    Clément K; van den Akker E; Argente J; Bahm A; Chung WK; Connors H; De Waele K; Farooqi IS; Gonneau-Lejeune J; Gordon G; Kohlsdorf K; Poitou C; Puder L; Swain J; Stewart M; Yuan G; Wabitsch M; Kühnen P;
    Lancet Diabetes Endocrinol; 2020 Dec; 8(12):960-970. PubMed ID: 33137293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and molecular genetic spectrum of congenital deficiency of the leptin receptor.
    Farooqi IS; Wangensteen T; Collins S; Kimber W; Matarese G; Keogh JM; Lank E; Bottomley B; Lopez-Fernandez J; Ferraz-Amaro I; Dattani MT; Ercan O; Myhre AG; Retterstol L; Stanhope R; Edge JA; McKenzie S; Lessan N; Ghodsi M; De Rosa V; Perna F; Fontana S; Barroso I; Undlien DE; O'Rahilly S
    N Engl J Med; 2007 Jan; 356(3):237-47. PubMed ID: 17229951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melanocortin 4 Receptor Pathway Dysfunction in Obesity: Patient Stratification Aimed at MC4R Agonist Treatment.
    Ayers KL; Glicksberg BS; Garfield AS; Longerich S; White JA; Yang P; Du L; Chittenden TW; Gulcher JR; Roy S; Fiedorek F; Gottesdiener K; Cohen S; North KE; Schadt EE; Li SD; Chen R; Van der Ploeg LHT
    J Clin Endocrinol Metab; 2018 Jul; 103(7):2601-2612. PubMed ID: 29726959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylphenidate in children with monogenic obesity due to LEPR or MC4R deficiency improves feeling of satiety and reduces BMI-SDS-A case series.
    Brandt S; von Schnurbein J; Lennerz B; Kohlsdorf K; Vollbach H; Denzer C; Bode H; Hebebrand J; Wabitsch M
    Pediatr Obes; 2020 Jan; 15(1):e12577. PubMed ID: 31670905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of mutations in LEP, LEPR, and MC4R genes in individuals with severe obesity.
    Paolini B; Maltese PE; Del Ciondolo I; Tavian D; Missaglia S; Ciuoli C; Zuntini M; Cecchin S; Bertelli M; Pompucci G
    Genet Mol Res; 2016 Aug; 15(3):. PubMed ID: 27706562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rare genetic forms of obesity: From gene to therapy.
    Clément K; Mosbah H; Poitou C
    Physiol Behav; 2020 Dec; 227():113134. PubMed ID: 32805220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphisms in Genes Involved in the Leptin-Melanocortin Pathway are Associated with Obesity-Related Cardiometabolic Alterations in a Southern Chilean Population.
    Manriquez V; Aviles J; Salazar L; Saavedra N; Seron P; Lanas F; Fajardo CM; Hirata MH; Hirata RDC; Cerda A
    Mol Diagn Ther; 2018 Feb; 22(1):101-113. PubMed ID: 28975585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eating behaviour in obese patients with melanocortin-4 receptor mutations: a literature review.
    Valette M; Bellisle F; Carette C; Poitou C; Dubern B; Paradis G; Hercberg S; Muzard L; Clément K; Czernichow S
    Int J Obes (Lond); 2013 Aug; 37(8):1027-35. PubMed ID: 23147118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential role of gender specific effect of leptin receptor deficiency in an extended consanguineous family with severe early-onset obesity.
    Dehghani MR; Mehrjardi MYV; Dilaver N; Tajamolian M; Enayati S; Ebrahimi P; Amoli MM; Farooqi S; Maroofian R
    Eur J Med Genet; 2018 Aug; 61(8):465-467. PubMed ID: 29545012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early childhood BMI trajectories in monogenic obesity due to leptin, leptin receptor, and melanocortin 4 receptor deficiency.
    Kohlsdorf K; Nunziata A; Funcke JB; Brandt S; von Schnurbein J; Vollbach H; Lennerz B; Fritsch M; Greber-Platzer S; Fröhlich-Reiterer E; Luedeke M; Borck G; Debatin KM; Fischer-Posovszky P; Wabitsch M
    Int J Obes (Lond); 2018 Sep; 42(9):1602-1609. PubMed ID: 29568105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MC4R agonism promotes durable weight loss in patients with leptin receptor deficiency.
    Clément K; Biebermann H; Farooqi IS; Van der Ploeg L; Wolters B; Poitou C; Puder L; Fiedorek F; Gottesdiener K; Kleinau G; Heyder N; Scheerer P; Blume-Peytavi U; Jahnke I; Sharma S; Mokrosinski J; Wiegand S; Müller A; Weiß K; Mai K; Spranger J; Grüters A; Blankenstein O; Krude H; Kühnen P
    Nat Med; 2018 May; 24(5):551-555. PubMed ID: 29736023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterozygous Genetic Variants in Autosomal Recessive Genes of the Leptin-Melanocortin Signalling Pathway Are Associated With the Development of Childhood Obesity.
    Šket R; Kotnik P; Bizjan BJ; Kocen V; Mlinarič M; Tesovnik T; Debeljak M; Battelino T; Kovač J
    Front Endocrinol (Lausanne); 2022; 13():832911. PubMed ID: 35574020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proopiomelanocortin Deficiency Treated with a Melanocortin-4 Receptor Agonist.
    Kühnen P; Clément K; Wiegand S; Blankenstein O; Gottesdiener K; Martini LL; Mai K; Blume-Peytavi U; Grüters A; Krude H
    N Engl J Med; 2016 Jul; 375(3):240-6. PubMed ID: 27468060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations between obesity candidate gene polymorphisms (fat mass and obesity-associated (FTO), melanocortin-4 receptor (MC4R), leptin (LEP) and leptin receptor (LEPR)) and dietary intake in pregnant women.
    Martins MC; Trujillo J; Freitas-Vilela AA; Farias DR; Rosado EL; Struchiner CJ; Kac G
    Br J Nutr; 2018 Aug; 120(4):454-463. PubMed ID: 29893663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melanocortin-4 Receptor Signalling: Importance for Weight Regulation and Obesity Treatment.
    Kühnen P; Krude H; Biebermann H
    Trends Mol Med; 2019 Feb; 25(2):136-148. PubMed ID: 30642682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A toddler with a novel LEPR mutation.
    Armağan C; Yılmaz C; Koç A; Abacı A; Ülgenalp A; Böber E; Erçal D; Demir K
    Hormones (Athens); 2019 Jun; 18(2):237-240. PubMed ID: 30778850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between LEPR, FTO, MC4R, and PPARG-2 polymorphisms with obesity traits and metabolic phenotypes in school-aged children.
    Almeida SM; Furtado JM; Mascarenhas P; Ferraz ME; Ferreira JC; Monteiro MP; Vilanova M; Ferraz FP
    Endocrine; 2018 Jun; 60(3):466-478. PubMed ID: 29679223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Setmelanotide: a promising advancement for pediatric patients with rare forms of genetic obesity.
    Trapp CM; Censani M
    Curr Opin Endocrinol Diabetes Obes; 2023 Apr; 30(2):136-140. PubMed ID: 36722447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.